Human tissue kallikrein 9: Production of recombinant proteins and specific antibodies

Biological Chemistry

Volumn 387, Issue 6, 2006, Pages 733-740

  Memari, Nader ^a,b   Grass, Linda ^a   Nakamura, Terukazu ^c   Karakucuk, Inci ^a   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Antibody generation; Cancer biomarkers; Human tissue kallikreins; Protein expression; Protein purification; Serine proteases

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; KALLIKREIN; KALLIKREIN 9; PLASMID VECTOR; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; CELL TRANSFORMATION; CONFERENCE PAPER; CROSS REACTION; ESCHERICHIA COLI; GENE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; KLK GENE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SERODIAGNOSIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CROSS REACTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; MALE; RECOMBINANT PROTEINS; RNA, MESSENGER; SEMINAL VESICLES; TESTIS;

MAMMALIA; ORYCTOLAGUS CUNICULUS; PROKARYOTA;

EID: 33745661022     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.092     Document Type: Conference Paper

References (38)

1. Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human tissue kallikrein 6 reveals that a trypsin-like tissue kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
2. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
3. Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and application in cancer. Mol. Cancer Res. 2, 257-280.
4. Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of tissue kallikreins in the stratum corneum. J. Invest. Dermatol. 124, 198-203.
5. Chang, A., Yousef, G.M., Jung, K., Meyts, E.R., and Diamandis, E.P. (2001). Identification and molecular characterization of five novel tissue kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in human testis and testicular cancer. Anticancer Res. 21, 3147-3152.
6. Chang, A., Yousef, G.M., Scorilas, A., Grass, L., Sismondi, P., Ponzone, R., and Diamandis, E.P. (2002). Human tissue kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. Br. J. Cancer 86, 1457-1464.
7. Christopoulos, T.K. and Diamandis, E.P. (1992). Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem. 64, 342-346.
8. Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265-312.
9. Collins, F.S. (1995). Positional cloning moves from perditional to traditional. Nat. Genet. 9, 347-350.
10. Diamandis, E.P. (1998). Prostate-specific antigen - its usefulness in clinical medicine. Trends Endocrinol. Metab. 9, 310-316.
11. Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, A., and Obiezu, C.V. (2000a). The new human tissue kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab. 11, 54-60.
12. Diamandis, E.P., Yousef, G.M., Clements, J., Ashworth, L.K., Yoshida, S., Egelrud, T., Nelson, P.S., Shiosaka, S., Little, S., Lilja, H., et al. (2000b). New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46, 1855-1858.
13. Diamandis, E.P., Scorilas, A., Fracchioli, S., Van Gramberen, M., de Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., Yousef, G.M., Stenman, U.H., et al. (2003). Human tissue kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 27, 1035-1043.
14. Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P.J., Nicklin, J., Samaratunga, H., and Clements, J.A. (2001). Human tissue kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res. 7, 2363-2371.
15. Gomis-Ruth, F.X., Bayes, A., Sotiropoulou, G., Pampalakis, G., Tsetsenis, T., Villegas, V., Aviles, F.X., and Coll, M. (2002). The structure of human protissue kallikrein 6 reveals a novel activation mechanism for the tissue kallikrein family. J. Biol. Chem. 277, 27273-27281.
16. Harlow, E. and Lane, D. (1988). Antibodies: A Laboratory Manual (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press).
17. Kumar, A., Mikolajczyk, S.D., Goel, A.S., Millar, L.S., and Saedi, M.S. (1997). Expression of the pro-form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human tissue kallikrein 2. Cancer Res. 57, 3111-3114.
18. Luo, L.Y., Rajpert-De Meyts, E.R., Jung, K., and Diamandis, E.P. (2001a). Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br. J. Cancer 85, 220-224.
19. Luo, L.Y., Grass, L., Howart, J.C., Thibault, P., Ong, H., and Diamandis, E.P. (2001b). Immunofluorometric assay of human tissue kallikrein 10 and its identification in biological fluids and tissues. Clin. Biochem. 47, 237-246.
20. Luo, L.Y., Diamandis, E.P., Look, M.P., Soosaipillai, A.P., and Foekens, J.A. (2002). Higher expression of human tissue kallikrein 10 in breast cancer tissue predicts tamoxifen resistance. Br. J. Cancer 86, 1790-1796.
21. Luo, L.Y., Katsaros, D., Scorilas, A., Fracchioli, S., Bellino, R., Van Gramberen, M., de Bruijn, H., Henrik, A., Stenman, U.H., Massobrio, M., Van der Zee, A.G., Vergote, I., and Diamandis, E.P. (2003a). The serum concentration of human tissue kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res. 63, 807-811.
22. Luo, L.Y., Yousef, G.M., and Diamandis, E.P. (2003b). Human tissue kallikreins and testicular cancer. APMIS 111, 225-232.
23. Luo, L.Y., Grass, L., and Diamandis, E.P. (2003c). Steroid hormone regulation of the human tissue kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter. Clin. Chim. Acta 337, 115-126.
24. Nakamura, T., Scorilas, A., Stephan, C., Jung, K., Soosaipillai, A.R., and Diamandis, E.R (2003). The usefulness of serum human tissue kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res. 63, 6543-6546.
25. Rittenhouse, H.G., Finlay, J.A., Mikolajczyk, S.D., and Partin, A.W. (1998). Human tissue kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, tissue kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci. 35, 275-368.
26. Stephan, C., Jung, K., Diamandis, E.P., Rittenhouse, H.G., Lein, M., and Loening, S.A. (2002). Prostate-specific antigen, its molecular forms, and other tissue kallikrein markers for detection of prostate cancer. Urology 59, 2-8.
27. Takayama, T.K., Carter, C.A., and Deng, T. (2001a). Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR. Biochemistry 40, 1679-1687.
28. Takayama, K.T., McMullen, B.A., Nelson, P.S., Matsumura, M., and Fujikawa, K. (2001b). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single chain urokinase-type plasminogen activator and degradation of prostates acid phosphatase. Biochemistry 40, 15341-15348.
29. Talieri, M., Diamandis, E.P., Gourgiotis, D., Mathioudaki, K., and Scorilas, A. (2004). Expression analysis of the human tissue kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb. Haemost. 97, 180-186.
30. Tanimoto, H., Underwood, L.J., Shigemasa, K., Yan, Y., Clarke, J., and O'Brien, T.J. (1999). The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 86, 2074-2082.
31. Yousef, G.M. and Diamandis, E.P. (2000). The expanded human tissue kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65, 184-194.
32. Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204.
33. Yousef, G.M., Kyriakopoulou, L.G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W.J., et al. (2001a). Quantitative expression of the human tissue kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res. 61, 7811-7818.
34. Yousef, G.M., Magklara, A., Chang, A., Jung, K., Katsaros, D., and Diamandis, E.P. (2001b). Cloning of a new member of the human tissue kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61, 3425-3431.
35. Yousef, G.M., Borgono, C.A., Scorilas, A., Ponzone, R., Biglia, N., Iskander, L., Polymeris, M.E., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002a). Quantitative analysis of human tissue kallikrein gene 14 expression in breast tumours indicates association with poor prognosis. Br. J. Cancer 87, 1287-1293.
36. Yousef, G.M., Scorilas, A., Kyriakopoulou, L.G., Rendl, L., Diamandis, M., Ponzone, R., Biglia, N., Giai, M., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002b). Human tissue kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin. Chem. 48, 1241-1250.
37. Yousef, G.M., Obiezu, C.V., Jung, K., Stephan, C., Scorilas, A., and Diamandis, E.P. (2002c). Differential expression of tissue kallikrein gene 5 in cancerous and normal testicular tissues. Urology 60, 714-718.
38. Yousef, G., Scorilas, A., Nakamura, T., Ellatif, M.A., Ponzone, R., Biglia, N., Maggiorotto, F., Roagna, R., Sismondi, P., and Diamandis, E.P. (2003). The prognostic value of the human tissue kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Res. Treat. 78, 149-158.